Sunshine Biopharma, Inc. (SBFM) Tops Q3 EPS by 2c

Sunshine Biopharma, Inc. (NASDAQ: SBFM) reported Q3 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $5.96 million versus the consensus estimate of $6 million.

For earnings history and earnings-related data on Sunshine Biopharma, Inc. (SBFM) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• T. Rowe Price (TROW) PT Raised to $110 at TD Cowen
• KeyBanc on National Fuel Gas (NFG): 'P&S Growth an Underappreciated Hedge to Weak Natural Gas Prices'